Search Results for 'week svr'

week svr published presentations and documents on DocSlides.

by ellena-manuel

Morris Sherman MD . BCh. PhD FRCP(C) . Associate...

by conchita-marotz

ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....

Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation

Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation

by ahmir653

SOLAR-2. Source: . Manns. M, et al. Lancet Infect...

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

Hepatitis C: A New Era In Treatment And Cure

Hepatitis C: A New Era In Treatment And Cure

by myesha-ticknor

Adam . Deising. , DO. LCDR MC USN. Director of . ...

Single arm Open label ≥

Single arm Open label ≥

by ellena-manuel

18 years. BMI ≥ 18 kg/m. 2. HCV genotype 2, 4, ...

SMV 150 mg QD SOF 400 mg QD

SMV 150 mg QD SOF 400 mg QD

by alida-meadow

Randomisation. 1 : 1. 18-70 years. HCV genotype 1...

by celsa-spraggs

400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...

Peginterferon alfa-2a (

Peginterferon alfa-2a (

by tatyana-admore

Pegasys. ). Prepared by: David Spach, MD & H....

Safety and Efficacy of Daclatasvir

Safety and Efficacy of Daclatasvir

by tabitha

. Plus . Sofosbuvir. With or Without Ribavirin . ...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

by sophia

April 10. –14. , 2019. Vienna, Austria. Disclaim...

The Paradox of Highly Effective

The Paradox of Highly Effective

by Kingslayer

Sofosbuvir. . Combo Therapy . Despite . Slow . He...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by webraph

Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...

Design Sofosbuvir / velpatasvir

Design Sofosbuvir / velpatasvir

by fullyshro

for 12 weeks in liver transplant recipients with g...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by lois-ondreau

Sameh W. Boktor, MD, MPH. Medical Epidemiologist....

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

by min-jolicoeur

Randomisation. Open-label. W8. * Liver biopsy or ...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by jane-oiler

(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

Current strategies for the management of treatment naïve a

Current strategies for the management of treatment naïve a

by min-jolicoeur

Mark S. Sulkowski, MD. Medical Director, Viral He...

by celsa-spraggs

Morris Sherman MD . BCh. PhD FRCP(C) . Associate...

Treatment of Hepatitis C in patients with

Treatment of Hepatitis C in patients with

by tatyana-admore

thalassaemia. . Where . are we now?. Telaprevir ....

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

by kittie-lecroy

Mark Sulkowski, MD . Professor of Medicine. Medic...